L3VLUP
ProSign in

WRBY · VRTX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

WRBYVRTX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • WRBY
  • VRTX
010203040202120222023202420252026
Holders and value by quarter
QuarterWRBYVRTX
Q3 2020none listed holders, n.a.31 holders, $21.9bn
Q4 2020none listed holders, n.a.30 holders, $18.4bn
Q1 2021none listed holders, n.a.31 holders, $15.4bn
Q2 2021none listed holders, n.a.30 holders, $12.7bn
Q3 20216 holders, $2.9bn35 holders, $10.1bn
Q4 20219 holders, $2.7bn28 holders, $12.4bn
Q1 20228 holders, $2.2bn23 holders, $16.1bn
Q2 20228 holders, $683m25 holders, $18.1bn
Q3 20225 holders, $490m22 holders, $18.4bn
Q4 20226 holders, $451m28 holders, $18.4bn
Q1 20235 holders, $341m26 holders, $21.4bn
Q2 20235 holders, $369m27 holders, $24.7bn
Q3 20237 holders, $436m33 holders, $24.3bn
Q4 20237 holders, $413m32 holders, $28.6bn
Q1 20247 holders, $362m31 holders, $29.8bn
Q2 20248 holders, $333m29 holders, $33.4bn
Q3 20248 holders, $364m27 holders, $33.5bn
Q4 20249 holders, $517m26 holders, $28.5bn
Q1 202510 holders, $334m21 holders, $35.4bn
Q2 20258 holders, $340m21 holders, $32.3bn
Q3 20259 holders, $408m22 holders, $25.9bn
Q4 20256 holders, $231m26 holders, $31.8bn
Q1 20268 holders, $203m25 holders, $31.8bn
Q2 20267 holders, $381m26 holders, $34.6bn
WRBY

Warby Parker Inc

Holders
9
Reported value
$408m
Buyers
2
Sellers
7

Breadth -5 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
VRTX

Vertex Pharmaceuticals Inc

Holders
22
Reported value
$25.9bn
Buyers
13
Sellers
10

Breadth +3 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2025

Among the 29 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only WRBY (7)

Artisan Partners LP, Durable Capital Partners LP, First Eagle Investment Management LLC, Marshall Wace LLP, Maverick Capital Ltd, PDT Partners LLC, Polen Capital Management LLC

Only VRTX (20)

AllianceBernstein LP, ARK Investment Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Fidelity (FMR LLC), Freestone Grove Partners LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Neuberger Berman Group LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Voloridge Investment Management LLC, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →